Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing

With this external quality assessment (EQA) scheme, we aim to investigate the diagnostic performance of the currently available methods for the detection of ALK alterations in non-small cell lung cancer on a national scale, namely, in situ hybridization (ISH), immunohistochemistry (IHC), and RNA/DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurmeister, Philipp, Vollbrecht, Claudia, Jöhrens, Korinna, Aust, Daniela, Behnke, Anke, Stenzinger, Albrecht, Penzel, Roland, Endris, Volker, Schirmacher, Peter, Fisseler-Eckhoff, Annette, Neumann, Jens, Kirchner, Thomas, Büttner, Reinhard, Merkelbach-Bruse, Sabine, Kreipe, Hans, Jonigk, Danny, Jochum, Wolfram, Rodriguez, Regulo, Dietel, Manfred, Horst, David, Hummel, Michael, von Laffert, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364534/
https://www.ncbi.nlm.nih.gov/pubmed/34173019
http://dx.doi.org/10.1007/s00428-021-03106-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364534/
https://www.ncbi.nlm.nih.gov/pubmed/34173019
http://dx.doi.org/10.1007/s00428-021-03106-5

Ejemplares similares